Marcelo H. Losso
Marcelo H. Losso
Head, HIV Unit, Hospital JM Ramos Mejia
Verified email at - Homepage
Cited by
Cited by
A randomized trial of convalescent plasma in Covid-19 severe pneumonia
VA Simonovich, LD Burgos Pratx, P Scibona, MV Beruto, MG Vallone, ...
New England Journal of Medicine 384 (7), 619-629, 2021
Major clinical outcomes in antiretroviral therapy (ART)–naive participants and in those not receiving ART at baseline in the SMART study
Strategies for Management of Antiretroviral Therapy (SMART) Study Group
The Journal of infectious diseases 197 (8), 1133-1144, 2008
Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy
JK Rockstroh, A Mocroft, V Soriano, C Tural, MH Losso, A Horban, O Kirk, ...
The Journal of infectious diseases 192 (6), 992-1002, 2005
Cabotegravir for HIV prevention in cisgender men and transgender women
RJ Landovitz, D Donnell, ME Clement, B Hanscom, L Cottle, L Coelho, ...
New England Journal of Medicine 385 (7), 595-608, 2021
Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study
N Friis-Mĝller, R Thiebaut, P Reiss, R Weber, A D'Arminio Monforte, ...
European journal of cardiovascular prevention & rehabilitation 17 (5), 491-501, 2010
Interleukin-2 therapy in patients with HIV infection
INSIGHT–ESPRIT Study Group and SILCAAT Scientific Committee
New England Journal of Medicine 361 (16), 1548-1559, 2009
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2 …
P Cahn, JS Madero, JR Arribas, A Antinori, R Ortiz, AE Clarke, CC Hung, ...
The Lancet 393 (10167), 143-155, 2019
Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study
A Mocroft, AN Phillips, J Gatell, B Ledergerber, M Fisher, N Clumeck, ...
The Lancet 370 (9585), 407-413, 2007
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
H Pan, R Peto, AMH Restrepo, MP Preziosi, V Sathiyamoorthy, QA Karim, ...
The Lancet 399 (10339), 1941-1953, 2022
Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study
JP Viard, JC Souberbielle, O Kirk, J Reekie, B Knysz, M Losso, J Gatell, ...
Aids 25 (10), 1305-1315, 2011
Sequence Analysis of In Vivo Defective Interfering-Like RNA of Influenza A H1N1 Pandemic Virus
K Saira, X Lin, JV DePasse, R Halpin, A Twaddle, T Stockwell, B Angus, ...
Journal of virology 87 (14), 8064-8074, 2013
Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial
SMART Study Group*
Annals of internal medicine 149 (5), 289-299, 2008
Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has …
M Aboud, R Kaplan, J Lombaard, F Zhang, JA Hidalgo, E Mamedova, ...
The Lancet infectious diseases 19 (3), 253-264, 2019
Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial
RT Davey, E Fernández-Cruz, N Markowitz, S Pett, AG Babiker, ...
The Lancet Respiratory Medicine 7 (11), 951-963, 2019
Tuberculosis-related mortality in people living with HIV in Europe and Latin America: an international cohort study
DN Podlekareva, AMW Efsen, A Schultze, FA Post, AM Skrahina, ...
The lancet HIV 3 (3), e120-e131, 2016
Infectious Disease Morbidity Among Young HIV-1–Exposed But Uninfected Infants in Latin American and Caribbean Countries: The National Institute of Child Health and Human …
MM Mussi-Pinhata, L Freimanis, AY Yamamoto, J Korelitz, JA Pinto, ...
Pediatrics 119 (3), e694-e704, 2007
When should antiretroviral therapy for HIV be started?
AN Phillips, BG Gazzard, N Clumeck, MH Losso, JD Lundgren
Bmj 334 (7584), 76-78, 2007
Pharmacokinetic parameters of nevirapine and efavirenz in relation to antiretroviral efficacy
FV Leth, BS Kappelhoff, D Johnson, MH Losso, A Boron-Kaczmarska, ...
AIDS Research & Human Retroviruses 22 (3), 232-239, 2006
A randomized trial to evaluate lopinavir/ritonavir versus saquinavir/ritonavir in HIV-1-infected patients: the MaxCmin2 trial
MaxCmin2 trial group, UB Dragsted, J Gerstoft, M Youle, Z Fox, M Losso, ...
Antiviral therapy 10 (6), 735-743, 2005
Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised …
JH Beigel, Y Bao, J Beeler, W Manosuthi, A Slandzicki, SM Dar, J Panuto, ...
The Lancet Infectious Diseases 17 (12), 1255-1265, 2017
The system can't perform the operation now. Try again later.
Articles 1–20